Yole Développement Announces Foundation of BLUMORPHO
News Feb 17, 2015
Yole Développement (Yole) announces the founding of daughter company, BLUMORPHO SAS. BLUMORPHO’s mission is to create value from all forms of innovation.
BLUMORPHO is developing businesses for its customers by building a dynamic marketplace and is active all along the innovation chain, from research to market.
The spin-off will undertake Yole Finance Innovation activities dedicated to supporting technology exploitation, young companies’ maturation and intellectual property portfolio optimization.
“BLUMORPHO is operating an innovative business model in marketing a portfolio of attractive technologies to serve industrial needs and demand”, explains Géraldine Andrieux Gustin, CEO & Co-founder of BLUMORPHO. “We facilitate access to technologies and innovations with added value for industrial companies. Based on Yole’s expertise, and our hands-on experience, we identify bankable challenges in different industries and we match them with relevant solutions and technologies to address those needs. As a trusted third party active throughout the ecosystem, BLUMORPHO supports successful innovation processes”, she adds.
The concept of this new business model has been tested and validated in the course of COWIN, which was initiated and led by Géraldine as Yole Finance’s Senior Partner. Sponsored by the European Commission, COWIN was dedicated to facilitating the commercial exploitation of results from European research projects on smart systems. From 2010 to 2014, COWIN generated about 25 million Euros’ worth of investment opportunities in technology exploitation.
“The launch of BLUMORPHO is a natural continuation of COWIN. BLUMORPHO will contribute to maintaining COWIN’s momentum by working in close collaboration with European technology owners engaged in driving their innovations to market,” highlighted BLUMORPHO’s CEO & Co-founder.
Methane Hydrate Formation Studied Using Novel MicroreactorNews
Researchers at the NYU Tandon School of Engineering are using a novel means of studying how methane and water form methane hydrate that allows them to examine discrete steps in the process faster and more efficiently.READ MORE
3-D-printed Biomaterials That Degrade On Demand DevelopedNews
The temporary structures, which can be degraded away with a biocompatible chemical trigger, could be useful in fabricating microfluidic devices, creating biomaterials that respond dynamically to stimuli and in patterning artificial tissue.READ MORE
Novel Multi-Organ-on-a-Chip Could Change Approaches to Drug DevelopmentNews
Researchers have successfully connected human tissues from the lung and liver in a novel multi-organ-on-a-chip (MOC) in vitro model for toxicity testing.READ MORE